Menu
Not yet recruiting NCT06847672

Comparison of the Time to Reach End-Tidal Oxygen Value of 90 and Oxygen Reserve Index Decline Times During Preoxygenation in Sarcopenic and Non-Sarcopenic Patients

— Observational Sarcopenia Preoxygenation Oxygen Reserve Index

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: preoxygenation.
Who it may be relevant to
Registry conditions: Sarcopenia, Preoxygenation, Oxygen Reserve Index. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Comparison of the Time to Reach End-Tidal Oxygen Value of 90 and Oxygen Reserve Index Decline Times During Preoxygenation in Sarcopenic and Non-Sarcopenic Patients Using the 6-Minute Walk Test

Overview

The purpose of this study is to compare the time required to reach an end-tidal oxygen (EtO2) value of 90% and the time until the Oxygen Reserve Index (ORI) drops below 0.55 during preoxygenation in sarcopenic and non-sarcopenic patients. The study aims to investigate the impact of sarcopenia on the oxygenation process.

Interventions

  • Diagnostic test preoxygenation
    The time required to reach EtO2 90% and the time until ORI drops below 0.55

Primary outcome measures

  • Time required to reach EtO2 90% [Time frame: preoperatively]
  • Time until ORI drops below 0.55 [Time frame: preoperatively]

Eligibility criteria

Inclusion criteria

  • Patients who agree to participate in the study.
  • Patients scheduled for major abdominal oncologic surgery.

Exclusion criteria

  • Patients with severe cardiopulmonary disease.
  • Patients with walking disabilities.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Turkey (Türkiye) · 1 center
  • Ankara City Hospital Bilkent — Ankara

Identifiers

NCT: NCT06847672 · TABED1-25-884

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗